- $3.06bn
- $1.84bn
- $9.18bn
- 59
- 68
- 32
- 52
Annual balance sheet for Oscar Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Net Total Receivables | 31.2 | 40.7 | 49.9 | 51.9 | 64.8 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 35.8 | 120 | 128 | 125 | 124 |
Long Term Investments | |||||
Insurance Receivables | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 2,272 | 3,322 | 4,527 | 3,601 | 4,840 |
Accounts Payable | |||||
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,823 | 1,934 | 3,636 | 2,798 | 3,827 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 449 | 1,387 | 890 | 804 | 1,014 |
Total Liabilities & Shareholders' Equity | 2,272 | 3,322 | 4,527 | 3,601 | 4,840 |
Total Common Shares Outstanding |